Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac L1/DFO Trial in Thalassemia
NCT00115349Phase 2Terminated
- Sponsor
- Elevance Health
- Start
- Jun 2005
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deferiprone in beta thalassemia, sponsored by Elevance Health. Started Jun 2005; status: terminated.
02
Drugs
deferiprone
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT00115349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115349.